Concepedia

Miranda Harteveld

MH

5

Publications

786

Citations

5

H-Index

1996

Active since

Affiliations

Rotterdam University of Applied Sciences(Current)

Erasmus MC Cancer Institute

Miranda Harteveld is an author at Rotterdam University of Applied Sciences specializing in medicine, drug discovery, and pharmacotherapy.

Top concepts

Publications per year

1996–2006

5

Publications

5

Vibrating microbubbles poking individual cells: Drug transfer into cells via sonoporation

Annemieke van Wamel, Klazina Kooiman, Miranda Harteveld et al. · Journal of Controlled Release · 2006 · 585 citations

, , +14

Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors.

L. Pronk, Jan H.M. Schellens, A.S.T. Planting et al. · Journal of Clinical Oncology · 1997 · 66 citations

Phase II and pharmacologic study of topotecan administered as a 21-day continuous infusion to patients with colorectal cancer.

G.J. Creemers, C J Gerrits, Jan H.M. Schellens et al. · Journal of Clinical Oncology · 1996 · 65 citations

Phase I and pharmacological study of the new topoisomerase I inhibitor GI147211, using a daily x 5 intravenous administration

CJH Gerrits, G.J. Creemers, JHM Schellens et al. · British Journal of Cancer · 1996 · 45 citations · Full text

, , +6

The bioavailability of oral GI147211 (GG211), a new topoisomerase I inhibitor

CJH Gerrits, JHM Schellens, G.J. Creemers et al. · British Journal of Cancer · 1997 · 25 citations · Full text

, , +7

Rows per page

1–5 of 5